Drugs / Neurapas balance
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT01047605 | Jan → Mar 2010 | — | Pascoe Pharmazeutische Praeparate GmbH | Completed | No outcome recorded |
| Phase 1 | NCT00997256 | Dec 2004 → Jan 2005 | sleep disorder | Pascoe Pharmazeutische Praeparate GmbH | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00997490 | Jan 2001 → Jul 2002 | depressive disorder | Pascoe Pharmazeutische Praeparate GmbH | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neurapas balance | “Neurapas balance, film-coated tablets” NCT00997256 ↗ |
| Known as | Neurapas balance, film-coated tablet | “Neurapas balance, film-coated tablet” NCT00997490 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “herbal preparation” NCT00997256 ↗ |